AI assistant
Egetis Therapeutics Major Shareholding Notification 2022
3152_iss_2022-05-20_82d69662-6bbf-4b36-aed4-47f65615c456.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Egetis Therapeutics AB (publ)
Holder
Flerie Invest AB
Instrument
| BTA SE0017770027 |
|---|
| 4,350,594 |
| 4,350,594 |
| Reason for major shareholding notification New share issue |
| 17/05/2022 |
| 5 % |
| 5 % |
| 12,087,069 |
| 12,087,069 |
| 0 |
| 5.63266 % |
| 5.63266 % |
| 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.63266 % | 12,087,069 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.63266 % | 12,087,069 |
| Group total holdings Voting rights 12,087,069 Percentage of voting rights 5.63266 |
||
| Published 20/05/2022 14:16 |
||
| Contact | ||
| Name Cecilia Scheele Phone +46706006856 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25